Heikki Kyykallio

Mr. Heikki Kyykallio


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
HKHeikki Kyykallio
Heikki Kyykallio
SOSanna Oikari
Sanna Oikari
MÁMaría Bueno Álvez
María Bueno Álvez
CGCarlos Gallardo
Carlos Gallardo
JCJanne Capra
Janne Capra
KRKirsi Rilla
Kirsi Rilla
Filopodia are multifunctional finger-like plasma membrane protrusions with bundles of actin filaments that exist in virtually all cell types. It has been known for some time that hyaluronan synthesis activity induces filopodial growth. However, because of technical challenges in the studies of these slender and fragile structures, no quantitative analyses have been performed so far to indicate their association with hyaluronan synthesis. In this work we comprehensively address the direct quantification of filopodial traits, covering for the first time length and density measurements in a series of human cancer cell lines with variable levels of hyaluronan synthesis. The synthesis and plasma membrane binding of hyaluronan were manipulated with hyaluronan synthase 3 (HAS3) and hyaluronan receptor CD44 overexpression, and treatments with mannose, 4-methylumbelliferone (4-MU), and glucosamine. The results of this work show that the growth of filopodia was associated with the levels of hyaluronan synthesis but was not dependent on CD44 expression. The results confirm the hypothesis that abundance and length of filopodia in cancer cells is associated with the activity of hyaluronan synthesis.

18 October 2022 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
HKHeikki Kyykallio
Heikki Kyykallio
AFAlessandra Faria
Alessandra Faria
RHRosabella Hartman
Rosabella Hartman
JCJanne Capra
Janne Capra
KRKirsi Rilla
Kirsi Rilla
PSPia Siljander
Pia Siljander
Recent advances in cell biology research regarding extracellular vesicles have highlighted an increasing demand to obtain 3D cell culture‐derived EVs, because they are considered to more accurately represent EVs obtained in vivo. However, there is still a grave need for efficient and tunable methodologies to isolate EVs from 3D cell cultures. Using nanofibrillar cellulose (NFC) scaffold as a 3D cell culture matrix, we developed a pipeline of two different approaches for EV isolation from cancer spheroids. A batch method was created for delivering high EV yield at the end of the culture period, and a harvesting method was created to enable time‐dependent collection of EVs to combine EV profiling with spheroid development. Both these methods were easy to set up, quick to perform, and they provided a high EV yield. When compared to scaffold‐free 3D spheroid cultures on ultra‐low affinity plates, the NFC method resulted in similar EV production/cell, but the NFC method was scalable and easier to perform resulting in high EV yields. In summary, we introduce here an NFC‐based, innovative pipeline for acquiring EVs from 3D cancer spheroids, which can be tailored to support the needs of variable EV research objectives.

26 March 2026 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
HKHeikki Kyykallio
Heikki Kyykallio
ESElena Scurti
Elena Scurti
MHMartina Hanzlíková
Martina Hanzlíková
KHKirsti Härkönen
Kirsti Härkönen
TSTuovi Salo
Tuovi Salo
KRKirsi Rilla
Kirsi Rilla
Cell recognition and uptake of extracellular vesicles (EVs) is mediated by a variety of surface molecules. Growing interest has recently been drawn towards glycan structures on EVs. Hyaluronic acid (HA) is a negatively charged glycosaminoglycan that can decorate the surface of EVs from different origins. HA is a ligand for adhesion receptor CD44, which is overexpressed in various cancers and inflammatory diseases. Although HA has been utilised as a surface decoration to improve CD44‐mediated targeting of synthetic nanoparticles and EVs, the role of CD44 in the uptake of EVs is not well known. To assess the importance of CD44 in the interactions and endocytosis of HA‐decorated EVs, uptake of HA‐decorated and nondecorated EVs into CD44‐expressing and ‐deficient cells was investigated using microscopic methods. The uptake of HA‐decorated EVs was significantly increased into cells that expressed CD44, but no differences in endocytosis mechanisms were found. Additionally, the formation of plasma‐derived protein corona in HA‐decorated and nondecorated EVs was investigated using multi‐parametric surface plasmon resonance and mass spectrometry. HA‐decoration was found to cause a formation of thicker corona and enrichment of plasma‐derived protein corona components. These findings highlight the role of HA in enhancing CD44‐mediated EV targeting and modulating the composition of protein corona.

10 August 2026 in Journal of Extracellular Biology
Verified
Journal Article
Open access
Lucia PaoliniLucia Paolini
Lucia Paolini
STSelene Tassoni
Selene Tassoni
KAKhuloud T. Al-Jamal
Khuloud T. Al-Jamal
XBXavier Banquy
Xavier Banquy
TBTamás Beke‐Somfai
Tamás Beke‐Somfai
Annalisa RadeghieriAnnalisa Radeghieri
Annalisa Radeghieri
The concept of the “biomolecular corona” (BC) was first introduced to describe the spontaneous absorption of molecules, mainly proteins, onto the surface of synthetic nanoparticles upon exposure to biological fluids. More recently, the same term has been used to describe biomolecules that dynamically interact with the surface of extracellular vesicles (EVs) during their biogenesis, secretion, or upon exposure to intracellular or extracellular milieus, including biological fluids. The EV biomolecular corona is a key determinant of EV identity, shaping their cellular uptake, biodistribution, and functional outcomes in both physiological and pathological contexts. EVs, in contrast to synthetic nanoparticles, introduce distinct challenges and perspectives due to their biological origin, innate heterogeneity, and complex combination of physicochemical and biological properties. To address this evolving topic, the International Society for Extracellular Vesicles (ISEV) organized a dedicated workshop in Brescia, Italy, on 27th to 28th February, 2025. The event gathered selected participants from academia and industry, with expertise spanning synthetic nanomaterials, EVs, biophysics, and translational nanomedicine. The program included keynote lectures, oral presentations, posters, and a series of interactive roundtables structured around fundamentals of the biomolecular corona, EV corona biogenesis and composition, analytical and separation tools and clinical and diagnostic potential applications. This report summarizes the key scientific insights, methodological challenges, conceptual debates, and future perspectives that emerged from the workshop.

29 August 2026 in Journal of Extracellular Biology
Verified
Journal Article
Open access
JMJohanna Matilainen
Johanna Matilainen
SFSanni Foster
Sanni Foster
VBViivi Berg
Viivi Berg
JTJanne Tampio
Janne Tampio
TTTanja Turunen
Tanja Turunen
KRKirsi Rilla
Kirsi Rilla
Recent studies have shown that adipose tissue (AT) secretes elevated levels of extracellular vesicles (EVs) in obesity, and these EVs play roles in metabolic diseases. The inhibition of calpains has anti‐inflammatory and anti‐fibrotic effects on AT in mice and reduces EV secretion in some cell types in vitro. However, its effects on human AT and adipocyte EV secretion remain unexplored. This study aimed to investigate calpeptin's effects on EV‐mediated communication and adipocyte function, offering potential insights into therapeutic approaches for metabolic diseases. Human Simpson Golabi Behmel Syndrome (SGBS) preadipocytes were differentiated and treated with calpeptin. EVs were isolated by standard ultracentrifugation, and studied by nanoparticle tracking analysis, electron microscopy, and mass spectrometry. Diverse analyses, including RNA‐sequencing, liquid chromatography–mass spectrometry (LC–MS), and confocal microscopy were utilized to study calpeptin's effects on SGBS cells. AT samples from bariatric surgery patients were cultured ex vivo to assess calpeptin's effects on primary AT. We demonstrated for the first time that calpeptin reduces EV secretion in human SGBS adipocytes. Proteomic analyses revealed that calpeptin alters the abundances of proteins related to EV secretory pathways. While reduced EV secretion was accompanied by anti‐inflammatory effects, calpeptin also altered insulin signalling pathways and reduced adiponectin expression, suggesting negative effects on adipocyte metabolism. Indeed, LC–MS analyses of cells and EVs revealed that calpeptin altered proteins—both in cells and EVs—that are associated with stress responses. Notably, calpeptin upregulated HO‐1 in vitro and in ex vivo AT cultures, indicating induced oxidative stress in adipocytes and AT. While calpeptin shows anti‐inflammatory promise in human SGBS adipocytes, its adverse effects on insulin signalling, adiponectin expression, and signs of oxidative stress raise concerns about its therapeutic potential against obesity‐related pathologies in humans. Our results highlight the need to understand the broader impact of calpeptin on adipocyte metabolism.